tirzepatide and sleep apnea VisualAbstract: Improved Outcomes in Patients with Obstructive Obesity FDA Approves Tirzepatide (Zepbound) as

Severe Digestive Complications Despite being newer, tirzepatide drugs are already associated with: Gastroparesis (stomach paralysis) Ileus (intestinal blockage) Severe persistent vomiting Gastric outlet obstruction Cyclic vomiting syndrome The mechanism is similar to semaglutide: excessive slowing of gastric emptying

[Abstract]2024 Dec 31:111368

Neck and dcollet patients often appreciate combining their visit with face treatments (cheek filler, jawline filler, temple filler) in the same appointment making the discreet office and consistent provider continuity practical

Diabetes Care 35 , 24022411

Research indicates that patients who discontinued Zepbound regained about half the weight they had originally lost over the course of a year, emphasizing the importance of ongoing treatment for maintaining weight loss